แบบแสดงรายการขอมูลการเสนอขายตราสารหน้ี (รายครั้ง) (แบบ 69-DEBT-PO-GOV.AGENCY) บริษัท........... (ช่ือไทย/อังกฤษของผูเสนอขายตราสารหน้ี) ............. เสนอขาย ......................................................................................................................... ......................................................................................................................... ....................................................................................................
arranged by the derivatives fund manager must possess knowledge, ability and business understanding and is subject to the approval of the Office in accordance with rules as prescribed in the notification of
arranged by the derivatives fund manager must possess knowledge, ability and business understanding and is subject to the approval of the Office in accordance with rules as prescribed in the notification of
arranged by the derivatives fund manager must possess knowledge, ability and business understanding and is subject to the approval of the Office in accordance with rules as prescribed in the notification of
sales was better from the same period of last year due to higher sales growth resulting in lower waste and ability to control key raw materials’ price. Selling Expenses Selling expenses of Q3’2018-2019
Verita has the ability to perform business which will be profitable in the future and can be used for loan repayment. For another 2 borrowers, BBW and DDAT who are not connected persons, the Company has an
respectively, an increase of THB 49.0 Mn or 4.5%. This increase was mainly due to (1) increase in revenue contribution of the brands with higher % cost of goods sold. (2) the increase of packaging cost related
to lower contribution from GHECO-One. • Financial costs decreased by 16.4% or THB 193.0 mm, compared to the same period of last year, due to accounting impact of early redemption of bond and lower
contribution from our subsidiaries outside Thailand. Revenue from Portugal operations increased slightly by 3.7%. China recorded a strong revenue growth of 24.3%. The company also recorded increase in revenue
overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative